
Abterra Biosciences
San Diego, CA, United States abterrabio.com From their website, Nov 2026
Work here? Claim this listing
About
Abterra Biosciences provides antibody sequencing and discovery services for researchers and biotech teams. It works on hybridomas, B cells, serum, display libraries, and purified proteins using sequencing, mass spectrometry, and machine learning. The company is based in San Diego, California.
Services
Reptor Hybridoma Sequencing
Next-generation sequencing of hybridomas to recover full-length variable region sequences, detect contaminating minor clones, assess clonality, and read out isotypes.
Reptor Bulk B Cell Sequencing
Next-generation sequencing of sorted B-cell populations and tissues to profile antibody repertoires with error correction and repertoire analysis.
Reptor Hit Expansion Sequencing
Bulk sequencing used to identify relatives of screened antibody hits and expand candidate diversity for discovery campaigns.
Reptor Display Library Sequencing
Next-generation sequencing of display libraries to assess diversity, germline gene representation, and CDR3 diversity.
Alicanto Rabbit Antibody Discovery
Custom rabbit monoclonal antibody discovery from serum with sequence-aware selection and recombinant candidate production.
Alicanto Single Domain Antibody Discovery
Single domain antibody discovery from serum, including llama and alpaca projects, with sequence reporting and candidate validation.
Alicanto Human Antibody Discovery
Human antibody discovery from serum for repertoire analysis and identification of monoclonal antibody candidates.
Valens Antibody Protein Sequencing
Mass spectrometry-based de novo sequencing of monoclonal antibodies directly from protein, recovering full-length heavy and light chain sequences.
Minimum 50ug of purified monoclonal antibody
3 more services
- Valens Protein Sequence Confirmation
- Griffin Polyclonal Antibody Sequencing
- Alicanto® Rabbit Monoclonal Antibody Discovery
- Turnaround
- 3 weeks
- 4 weeks
- What to send
- >10k cells per hybridoma
- 100–5M cells
- Cryovials and plates
- DNA or purified phage or yeast
- 50ug of purified monoclonal antibody
- 100ug of 90% pure protein
7 more
- 2.5 mg of antigen for immunization, affinity purification, and ELISA
- Antibody protein
- Serum
- Hybridoma
- Bulk B cells
- Display library
- Target
Capabilities
- Assays and studies
- Antibodies
- Hybridoma
- NGS
- Mass spectrometry
- Machine learning
- Error correction
7 more
- Repertoire analysis
- Clonality assessment
- CDR detection
- Protein sequence confirmation
- De novo sequencing
- Next-generation sequencing
- Proteomic de novo sequencing
- Scale and capacity
- Start from as few as 10,000 cells per hybridoma
- 100–5M cells for bulk B-cell sequencing
- Tissue pieces no larger than 1 cm in any dimension
- Work performed 100% in the USA
- 4 technologies
- 9 services
- Therapeutic areas
- Infectious diseases
- Cancer
- Autoimmune diseases
- Oncology
- Diagnostics
Instruments and platforms
- Next-generation sequencing platforms
- Mass spectrometry
- Next-generation sequencing
Modalities and species
- Modalities
- Antibody
- Recombinant protein
- Species and models
- Mouse
- Rat
- Rabbit
- Human
- Transgenics
- Llama
4 more
- Alpaca
- Hybridoma
- B cells
- Serum
Industries served
- Biotech
- Diagnostics
- Research
- Therapeutics
- Vaccine design
- Bioanalysis
Company
- Type
- CRO
- Founded
- 2009
- Ownership
- Small business, as registered with SAM.gov or stated on their site
Locations
- Address
- 11588 Sorrento Valley Road, Ste 16 San Diego, CA 92121
- Serves
- USA
Contacts
- Phone
- (888) 416-9305
Public records
- Biocom California CRO directory
- antibody sequencing, next-generation sequencing, single domain antibody discovery source